Literature DB >> 11010978

Modulation of amyloid precursor protein metabolism by X11alpha /Mint-1. A deletion analysis of protein-protein interaction domains.

H T Mueller1, J P Borg, B Margolis, R S Turner.   

Abstract

Modulation of amyloid precursor protein (APP) metabolism plays a pivotal role in the pathogenesis of Alzheimer's disease. The phosphotyrosine-binding/protein interaction (PTB/PI) domain of X11alpha, a neuronal cytosolic adaptor protein, binds to the YENPTY sequence in the cytoplasmic carboxyl terminus of APP. This interaction prolongs the half-life of APP and inhibits Abeta40 and Abeta42 secretion. X11alpha/Mint-1 has multiple protein-protein interaction domains, a Munc-18 interaction domain (MID), a Cask/Lin-2 interaction domain (CID), a PTB/PI domain, and two PDZ domains. These X11alpha protein interaction domains may modulate its effect on APP processing. To test this hypothesis, we performed a deletion analysis of X11alpha effects on metabolism of APP(695) Swedish (K595N/M596L) (APP(sw)) by transient cotransfection of HEK 293 cells with: 1) X11alpha (X11alpha-wt, N-MID-CID-PTB-PDZ-PDZ-C), 2) amino-terminal deletion (X11alpha-DeltaN, PTB-PDZ-PDZ), 3) carboxyl-terminal deletion (X11alpha-DeltaPDZ, MID-CID-PTB), or 4) deletion of both termini (PTB domain only, PTB). The carboxyl terminus of X11alpha was required for stabilization of APP(sw) in cells. In contrast, the amino terminus of X11alpha was required to stimulate APPs secretion. X11alpha, X11alpha-DeltaN, and X11alpha-PTB, but not X11alpha-DeltaPDZ, were effective inhibitors of Abeta40 and Abeta42 secretion. These results suggest that additional protein interaction domains of X11alpha modulate various aspects of APP metabolism.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11010978     DOI: 10.1074/jbc.M008453200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  21 in total

1.  A role for Mints in transmitter release: Mint 1 knockout mice exhibit impaired GABAergic synaptic transmission.

Authors:  Angela Ho; Wade Morishita; Robert E Hammer; Robert C Malenka; Thomas C Sudhof
Journal:  Proc Natl Acad Sci U S A       Date:  2003-01-23       Impact factor: 11.205

2.  Autoinhibition of Mint1 adaptor protein regulates amyloid precursor protein binding and processing.

Authors:  Maria F Matos; Yibin Xu; Irina Dulubova; Zbyszek Otwinowski; John M Richardson; Diana R Tomchick; Josep Rizo; Angela Ho
Journal:  Proc Natl Acad Sci U S A       Date:  2012-02-21       Impact factor: 11.205

3.  X11alpha haploinsufficiency enhances Abeta amyloid deposition in Alzheimer's disease transgenic mice.

Authors:  Inderjeet Saluja; Henry Paulson; Ashwin Gupta; R Scott Turner
Journal:  Neurobiol Dis       Date:  2009-07-23       Impact factor: 5.996

4.  Identification of NEEP21 as a ß-amyloid precursor protein-interacting protein in vivo that modulates amyloidogenic processing in vitro.

Authors:  Eric M Norstrom; Can Zhang; Rudolph Tanzi; Sangram S Sisodia
Journal:  J Neurosci       Date:  2010-11-17       Impact factor: 6.167

5.  Novel mediators of amyloid precursor protein signaling.

Authors:  Andrzej Swistowski; Qiang Zhang; Mark E Orcholski; Danielle Crippen; Cathy Vitelli; Alexei Kurakin; Dale E Bredesen
Journal:  J Neurosci       Date:  2009-12-16       Impact factor: 6.167

Review 6.  Cytoplasmic tail adaptors of Alzheimer's amyloid-beta protein precursor.

Authors:  Masaoki Kawasumi; Shuji Matsuda; Masaaki Matsuoka; Ikuo Nishimoto
Journal:  Mol Neurobiol       Date:  2004-10       Impact factor: 5.590

Review 7.  Regulated proteolysis of APP and ApoE receptors.

Authors:  Hyang-Sook Hoe; G William Rebeck
Journal:  Mol Neurobiol       Date:  2008-04-15       Impact factor: 5.590

8.  X11 proteins regulate the translocation of amyloid beta-protein precursor (APP) into detergent-resistant membrane and suppress the amyloidogenic cleavage of APP by beta-site-cleaving enzyme in brain.

Authors:  Yuhki Saito; Yoshitake Sano; Robert Vassar; Sam Gandy; Tadashi Nakaya; Tohru Yamamoto; Toshiharu Suzuki
Journal:  J Biol Chem       Date:  2008-10-09       Impact factor: 5.157

Review 9.  Signal transduction therapeutics: relevance for Alzheimer's disease.

Authors:  Odete A B da Cruz e Silva; Margarida Fardilha; Ana Gabriela Henriques; Sandra Rebelo; Sandra Vieira; Edgar F da Cruz e Silva
Journal:  J Mol Neurosci       Date:  2004       Impact factor: 3.444

10.  X11beta rescues memory and long-term potentiation deficits in Alzheimer's disease APPswe Tg2576 mice.

Authors:  Jacqueline C Mitchell; Belall B Ariff; Darran M Yates; Kwok-Fai Lau; Michael S Perkinton; Boris Rogelj; John D Stephenson; Christopher C J Miller; Declan M McLoughlin
Journal:  Hum Mol Genet       Date:  2009-09-10       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.